The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I, first-in-human study of AbGn-107, a novel antibody-drug conjugate (ADC), in patients with gastric, colorectal, pancreatic or biliary cancers.
 
Andrew H. Ko
Honoraria - Clinical Care Options; Dava Oncology; Elsevier; OncLive; PER; Pharmatecture; PlatformQ Health; Research to Practice; Xcenda
Consulting or Advisory Role - ERYTECH Pharma; Gilead Sciences; Gritstone Bio; Imugene; MORE Health; SynCoreBio
Speakers' Bureau - Clinical Care Options
Research Funding - AbGenomics International (Inst); Apexigen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Halozyme (Inst); Merck (Inst); Merrimack (Inst)
 
Andrew L. Coveler
Consulting or Advisory Role - Abbvie; Halozyme; Merrimack; Seagen
Research Funding - AbGenomics International (Inst); Amgen (Inst); Amgen (Inst); Genentech (Inst); Gilead Sciences (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); MedImmune (Inst); Newlink Genetics (Inst); Novocure (Inst); Onconova Therapeutics (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Abbvie; Halozyme
 
Benjamin L. Schlechter
No Relationships to Disclose
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Abbvie; Amgen (Inst); Bayer (Inst); Celgene (Inst); Immuneering; Imugene; Incyte (Inst); Ipsen (Inst); Lilly (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Other Relationship - ARMO BioSciences; AstraZeneca; Exelixis; Merck (Inst); Sillajen
 
Brian M. Wolpin
Honoraria - Celgene; G1 Therapeutics
Consulting or Advisory Role - BioLineRx; Celgene; G1 Therapeutics; Genentech; GRAIL; GRAIL
Research Funding - Celgene; Lilly
 
Jeffrey William Clark
Consulting or Advisory Role - Emas pharma
Research Funding - Pfizer (Inst)
 
Bruno Bockorny
Research Funding - Nanoview Diagnostics
Travel, Accommodations, Expenses - ERYTECH Pharma
 
Li-Yuan Bai
No Relationships to Disclose
 
Yi-Lin Cheng
Employment - AbGenomics International
 
Ting-Ying Cheng
Employment - AbGenomics International
Travel, Accommodations, Expenses - AbGenomics International
 
Peter J. Langecker
Employment - Clinipace
Stock and Other Ownership Interests - Los Gatos Pharmaceuticals
Consulting or Advisory Role - Clinipace
Patents, Royalties, Other Intellectual Property - Los Gatos Pharmaceuticals
Travel, Accommodations, Expenses - Clinipace
 
Shih-Yao Lin
Employment - AbGenomics International
Leadership - AbGenomics International
Stock and Other Ownership Interests - AbGenomics International
Patents, Royalties, Other Intellectual Property - AbGenomics International